Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-04-07
2000-09-19
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548454, 548455, A61K 314015, A61K 31404, C07D40502, C07D20904, C07D20902
Patent
active
061213071
ABSTRACT:
Compounds useful for alleviating symptoms of depression are provided which have the following formula: wherein:
REFERENCES:
patent: 3371098 (1968-02-01), Kralt et al.
patent: 4314943 (1982-02-01), Kreighbaum et al.
patent: 5436264 (1995-07-01), Pfister et al.
patent: 5750724 (1998-05-01), Kang et al.
Sleight, A. J. et al., "Identification of 5-hydroxytryptamine1A Receptor Agents Using A Composite Pharmacophore Analysis and Chemical Database Screening", Naunyn-Schmiedeberg's Archives of Pharmacology, 343:109-16 (1991).
Nelson, D. L., "Structure-Activity Relationships at 5-HT1A receptors: Binding Profiles and Intrinsic Activity", Pharmacology Biochemistry & Behavior, 40(4):1041-51 (1991).
Glennon, R. A., "Concepts for the design of 5-HT1A serotonin agonists and antagonists", Drug Development Research, 26(3):251-274 (1992).
Le Poul et al., Arch. Pharmacol., 352:141 (1995).
Artigas et al., Trends Neurosci., 19:378-383 (1996).
Mewshaw Richard E.
Zhou Dahui
American Home Products Corp.
Desai Rita
Nagy Michael R.
Rotman Alan L.
LandOfFree
N-aryloxyethyl-indoly-alkylamines for the treatment of depressio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-aryloxyethyl-indoly-alkylamines for the treatment of depressio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-aryloxyethyl-indoly-alkylamines for the treatment of depressio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1073684